Researchers explore a new use for prazosin.
A groundbreaking study reveals an ultra-rare genomic variant often presents in patients with schizophrenia, providing more information on effective treatment options for a complicated disorder.
A new study may help men make more informed decisions about prostate cancer treatment.
A new study could lead to better tailoring of treatments to individual patients.
A new study finds that decreases in two osteoporosis risk factors — smoking and heavy alcohol use — help account for a steady drop in hip fracture rates in the U.S. over 40 years.
While COVID-19 caused many to shy away from in-person visits with a healthcare provider, a Healthgrades study published in May notes that consumer confidence is on the upswing. The COVID-19 Patient Confidence Study, a weekly...
Game theory could be the key to identifying dangerous antimicrobial-resistant bacteria.
Current antibiotic treatments for Clostridioides difficile infection (CDI), which causes the chronic, degenerative disease colitis, eliminate beneficial bacteria in the gut along with the harmful pathogen. Researchers at North Carolina State University (NCSU) have taken the first step toward developing a therapy that attacks C. difficile while sparing other microbes.
Two recently approved treatments show promise in a new study.
The recent FDA approval of the drug Tukysa (tucatinib) for use with the chemotherapeutic agents trastuzumab and capecitabine provides a new treatment option to certain adults with HER2-positive breast cancer.
- 1 of 13
- next ›